Literature DB >> 2754689

Acute proptosis and blindness in a patient with orbital phycomycosis.

R C Humphry1, G Wright, W J Rich, R Simpson.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2754689      PMCID： PMC1292144          DOI： 10.1177/014107688908200523

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  Cerebral nucormycosis (phycomycosis), Ocular findings and review of literatue.

Authors:  A P FERRY
Journal:  Surv Ophthalmol       Date:  1961-02       Impact factor: 6.048

2.  Ocular manifestations of acute mucormycosis.

Authors:  J D GASS
Journal:  Arch Ophthalmol       Date:  1961-02

3.  Orbital mucormycosis with survival.

Authors:  M O'Keefe; W M Haining; J D Young; W Guthrie
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

4.  Survival in orbital phycomycosis.

Authors:  M Best; S A Obstbaum; B Friedman; R J Strobos
Journal:  Am J Ophthalmol       Date:  1971-05       Impact factor: 5.258

Review 5.  Ocular and orbital phycomycosis.

Authors:  J N Schwartz; E H Donnelly; G K Klintworth
Journal:  Surv Ophthalmol       Date:  1977 Jul-Aug       Impact factor: 6.048

6.  Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases.

Authors:  N A Parfrey
Journal:  Medicine (Baltimore)       Date:  1986-03       Impact factor: 1.889
  6 in total
  3 in total

Review 1.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

2.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes.

Authors:  A Bhansali; S Bhadada; A Sharma; V Suresh; A Gupta; P Singh; A Chakarbarti; R J Dash
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.